[S-20] Symposium 20 Cutting-edge advances in NMOSD and MOG-related disorders

[S-20-3] Treatment of AQP4-IgG-positive NMOSD

^○Kazuo Fujihara^1,2 (1.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, Japan, 2.Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Japan)

Kazuo Fujihara, M.D.is Professor, Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, and Director, Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama, Japan. He is currently serving as President (2018~) of Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS), and President (2019~) of Japanese Society for Neuroimmunology (JSNI).